Levodopa/Carbidopa Oral: Dosing and Precautions
Levodopa and carbidopa guidance for Parkinson's disease and non-antipsychotic extrapyramidal disorders, with gradual titration and psychiatric precautions.
Also searched as
Source reviewed
April 2024
Guide category
Oral drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Antiparkinson drug.
Indications
Parkinson's disease and extrapyramidal disorders except those induced by antipsychotics.
Forms and strengths
- 100 mg levodopa + 10 mg carbidopa tablet.
- 250 mg levodopa + 25 mg carbidopa tablet.
Dose
Doses are expressed as levodopa.
- Adult: initial dose 50 to 125 mg 3 times daily, immediately after meals.
- Increase by 50 to 125 mg every day or every 2 days until the optimal dose for the individual patient is reached.
- Maintenance dose usually: 250 to 500 mg 3 times daily, immediately after meals, maximum 2 g daily.
- Reduce dosage in older patients.
Duration
According to clinical response.
Contra-indications, adverse effects, precautions
- Do not administer in severe psychosis, confusion, closed-angle glaucoma, recent myocardial infarction, or malignant melanoma.
- Early in treatment when dose is not adjusted, may cause anorexia, vomiting, orthostatic hypotension, cardiac arrhythmia, agitation, insomnia or drowsiness, and depression.
- Frequent delayed adverse effects or signs of excessive dosage include dyskinesia and tremor.
- Mental disorders are more frequent in older patients and may include confusional state or depression with or without suicidal tendencies.
- Later in treatment, fluctuation of effect during the day or reduction of effect may occur.
- Administer with caution in mental disorders, cardiac disease, and gastroduodenal ulcer.
- Do not administer simultaneously with MAOI antidepressants, antipsychotics, or reserpine.
- Pregnancy: contraindicated.
- Breast-feeding: contraindicated.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.
